In vitro antimicrobial susceptibility of Staphylococcus pseudintermedius isolates of human and animal origin

Romney M. Humphries, Max T. Wu, Lars F. Westblade, Amy E. Robertson, Carey Ann D. Burnham, Meghan A. Wallace, Eileen M. Burd, Sara Lawhon, Janet A. Hindler

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

MIC results for 115 Staphylococcus intermedius group isolates are presented. Of these, 33% were methicillin resistant, among which 51.4% were susceptible to doxycycline, 29.7% to clindamycin, and 21.6% to trimethoprim-sulfamethoxazole. All of the isolates were susceptible to ceftaroline, daptomycin, linezolid, nitrofurantoin, quinupristin-dalfopristin, rifampin, tigecycline, and vancomycin. Of all the isolates, 82.6%, 67.8%, and 23.5% were susceptible to ciprofloxacin, erythromycin, and penicillin, respectively. No isolates harbored mupA or qacA/B genes, which suggested a lack of resistance to mupirocin or chlorhexidine.

Original languageEnglish
Pages (from-to)1391-1394
Number of pages4
JournalJournal of clinical microbiology
Volume54
Issue number5
DOIs
StatePublished - May 2016

Fingerprint

Dive into the research topics of 'In vitro antimicrobial susceptibility of Staphylococcus pseudintermedius isolates of human and animal origin'. Together they form a unique fingerprint.

Cite this